Ministry Of Health Looks To India For Low Cost Drugs

February 2008 | Industry News

Patient groups in Yemen are arguing that a decision by the Ministry of Health to substitute a patented drug used in kidney transplant operations with a generic version from India is putting patient safety at risk. The drug had previously been sourced from Germany. However, a new tender was awarded to an Indian drugmaker, which, according to the Ministry of Health, offered a more competitively priced

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.